Prot #3-001: A RANDOMIZED, DOUBLE–BLIND, PLACEBO–CONTROLLED, PHASE-3 STUDY TO ASSESS THE SAFETY AND EFFICACY OF ART-123 IN SUBJECTS WITH SEVERE SEPSIS AND COAGULOPATHY

Project: Research project

Project Details

StatusFinished
Effective start/end date11/27/1211/27/18

Funding

  • Asahi Kasei Pharma America Corp. (Prot #3-001)